4D Molecular Therapeutics, Inc. (FDMT) Earnings
4D Molecular Therapeutics, Inc. is expected to report next earnings on August 10, 2026 (in NaN days), with a consensus EPS estimate of $-0.97. FDMT has beaten EPS estimates in 5 of its last 12 reported quarters (average surprise +40.6% over the last four).
Next earnings
Aug 10, 2026in NaN days
EPS est $-0.97 · Revenue est $3M
Track record
Beat EPS in 5 of 12 quarters
Avg surprise +40.6% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 7, 2026 | $-0.97 | $-1.01 | -4.1% | $3M | +17.8% |
| Mar 18, 2026 | $-0.53 | $0.43 | +181.4% | $-119000 | -100.4% |
| May 8, 2025 | $-0.84 | $-0.86 | -2.4% | $14000 | -97.4% |
| Feb 28, 2025 | $-0.80 | $-0.90 | -12.5% | $1000 | -100.0% |
| Aug 8, 2024 | $-0.72 | $-0.63 | +12.5% | $5000 | -99.6% |
| May 9, 2024 | $-0.73 | $-0.66 | +9.6% | $28000 | -96.4% |
| Feb 29, 2024 | $-0.68 | $-0.77 | -13.2% | $19000 | -99.2% |
| Nov 9, 2023 | $-0.67 | $-0.24 | +64.2% | $20M | +880.8% |
| Mar 15, 2023 | $-0.75 | $-0.84 | -12.0% | $1M | -58.6% |
| Aug 11, 2022 | $-0.78 | $-0.87 | -11.5% | $162000 | -81.1% |
| May 12, 2022 | $-0.73 | $-0.82 | -12.3% | $1M | +60.7% |
| Nov 10, 2021 | $-0.83 | $-0.82 | +1.2% | $1M | -1.2% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.